Last reviewed · How we verify
everolimus + mycophenolate mofetil — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
everolimus + mycophenolate mofetil (everolimus + mycophenolate mofetil) — Centre Hospitalier Universitaire, Amiens.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| everolimus + mycophenolate mofetil TARGET | everolimus + mycophenolate mofetil | Centre Hospitalier Universitaire, Amiens | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- everolimus + mycophenolate mofetil CI watch — RSS
- everolimus + mycophenolate mofetil CI watch — Atom
- everolimus + mycophenolate mofetil CI watch — JSON
- everolimus + mycophenolate mofetil alone — RSS
Cite this brief
Drug Landscape (2026). everolimus + mycophenolate mofetil — Competitive Intelligence Brief. https://druglandscape.com/ci/everolimus-mycophenolate-mofetil. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab